Skip to main content
. Author manuscript; available in PMC: 2013 Jun 17.
Published in final edited form as: J Am Coll Surg. 2009 May;208(5):906–916. doi: 10.1016/j.jamcollsurg.2009.01.035

Table 4.

Final Surgical Outcomes According to Baseline Surgical Category

Preoperative
assessment		 n* BCS Mastectomy Conversion (%)
Marginal for BCS 46 30 16 30/46 (65)
Ineligible for BCS 39 15 24 15/39 (38)
Inoperable 11 3 8 3/11 (27)
Total 96 48 48 48/96 (50)
*

One patient refused operation; two patients were not operable because of unassociated illness and comorbidities and seven patients with Response Evaluation Criteria in Solid Tumors progressive disease received neoadjuvant chemotherapy followed by breast-conserving surgery (n = 3) or mastectomy (n = 4).

BCS, breast-conserving surgery.